Hai-min Zhang

No 301, Yanchang Mid Road
Shanghai, 200072, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

circPRRC2A promotes angiogenesis and metastasis through epithelial-mesenchymal transition and upregulates TRPM3 in renal cell carcinoma.

circPRRC2A promotes angiogenesis and metastasis through epithelial-mesenchymal transition and upregulates TRPM3 in renal cell carcinoma.

Journal: Theranostics

Published: December 19, 2019

Decreased expression of BRAF-activated long non-coding RNA is associated with the proliferation of clear cell renal cell carcinoma.

Decreased expression of BRAF-activated long non-coding RNA is associated with the proliferation of clear cell renal cell carcinoma.

Journal: BMC urology

Published: February 11, 2018

Retrospective analysis of fosfomycin combinational therapy for sepsis caused by carbapenem-resistant Klebsiella pneumoniae.

Retrospective analysis of fosfomycin combinational therapy for sepsis caused by carbapenem-resistant Klebsiella pneumoniae.

Journal: Experimental and therapeutic medicine

Published: August 23, 2015

Correction: MiR-506 Is Down-Regulated in Clear Cell Renal Cell Carcinoma and Inhibits Cell Growth and Metastasis via Targeting FLOT1.

Correction: MiR-506 Is Down-Regulated in Clear Cell Renal Cell Carcinoma and Inhibits Cell Growth and Metastasis via Targeting FLOT1.

Journal: PloS one

Published: May 27, 2015

Upregulation of long non-coding RNA MALAT1 correlates with tumor progression and poor prognosis in clear cell renal cell carcinoma.

Upregulation of long non-coding RNA MALAT1 correlates with tumor progression and poor prognosis in clear cell renal cell carcinoma.

Journal: Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine

Published: September 09, 2014

MiR-506 is down-regulated in clear cell renal cell carcinoma and inhibits cell growth and metastasis via targeting FLOT1.

MiR-506 is down-regulated in clear cell renal cell carcinoma and inhibits cell growth and metastasis via targeting FLOT1.

Journal: PloS one

Published: July 21, 2014

Ratio of prostate specific antigen to the outer gland volume of prostrate as a predictor for prostate cancer.

Ratio of prostate specific antigen to the outer gland volume of prostrate as a predictor for prostate cancer.

Journal: International journal of clinical and experimental pathology

Published: July 17, 2014

High expression of long non-coding RNA SPRY4-IT1 predicts poor prognosis of clear cell renal cell carcinoma.

High expression of long non-coding RNA SPRY4-IT1 predicts poor prognosis of clear cell renal cell carcinoma.

Journal: International journal of clinical and experimental pathology

Published: July 02, 2014

Up-regulation of flotillin-2 is associated with renal cell carcinoma progression.

Up-regulation of flotillin-2 is associated with renal cell carcinoma progression.

Journal: Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine

Published: June 24, 2014

Primary angiosarcoma of the kidney: case analysis and literature review.

Primary angiosarcoma of the kidney: case analysis and literature review.

Journal: International journal of clinical and experimental pathology

Published: May 17, 2014

Bromodomain 4 protein is a predictor of survival for urothelial carcinoma of bladder.

Bromodomain 4 protein is a predictor of survival for urothelial carcinoma of bladder.

Journal: International journal of clinical and experimental pathology

Published: March 16, 2014

Effect of free radical scavenger on c-jun activation in rats with crush syndrome.

Effect of free radical scavenger on c-jun activation in rats with crush syndrome.

Journal: International journal of clinical pharmacology and therapeutics

Published: April 25, 2013

Showing 1-12 of 13

Last Updated: 09/26/2026